High Age Increases the Risk of Complications and Reduces Survival Following Esophagectomy for Adenocarcinoma
Journal of Surgery
Volume 6, Issue 1, February 2018, Pages: 1-7
Received: Nov. 8, 2017; Accepted: Nov. 16, 2017; Published: Dec. 14, 2017
Views 1847      Downloads 126
Authors
Daniel Willy Kjaer, Department of Surgery, Aarhus University Hospital, Aarhus, Denmark
Kaare Terp Fjerderholt, Department of Surgery, Aarhus University Hospital, Aarhus, Denmark
Jakob Kirkegaard, Department of Surgery, Aarhus University Hospital, Aarhus, Denmark
Cecilie Okholm, Department of Surgical Gastroenterology, Rigshospitalet, Copenhagen, Denmark
Michael Patrick Achiam, Department of Surgical Gastroenterology, Rigshospitalet, Copenhagen, Denmark
Lars Bo Svendsen, Department of Surgical Gastroenterology, Rigshospitalet, Copenhagen, Denmark
Frank Viborg Mortensen, Department of Surgery, Aarhus University Hospital, Aarhus, Denmark
Article Tools
Follow on us
Abstract
Introduction: The aim of the present study was to investigate the impact of high age and comorbidities in relation to postoperative complications, mortality, and long-term survival in patients undergoing surgery for adenocarcinoma of the esophagus and gastro-esophageal junction (GEJ). Methods: A cohort study of 557 patients operated for adenocarcinoma of the esophagus and GEJ. Data were collected from a prospectively maintained database, the Danish National Patient Registry, and medical records. Univariate and multivariate statistical models were used to analyze data after stratification for possible confounders. Results: The incidence of postoperative complications increased in patients aged ≥ 75 years compared with younger patients (OR: 1.57; 95% CI: 0.93-2.62) although not significant. However, testing for trend revealed a linear increase with age for severe complications (p=0.005). Age ≥ 75 years was also associated with increased 90-day but not 30-day mortality (HR: 5.05; 95% CI: 1.70-14.94 and HR: 3.47; 95% CI: 0.61-19.72 respectively). Overall survival decreased with increasing age (p=0.036). Conclusion: We found high age as an independent risk factor for death within 90 days but not 30 days after surgery for adenocarcinoma of the esophagus and GEJ. The presence of co-morbidity seemed to increase the risk for postoperative complications.
Keywords
Esophageal Neoplasms, Adenocarcinoma, Aged, Esophagectomy
To cite this article
Daniel Willy Kjaer, Kaare Terp Fjerderholt, Jakob Kirkegaard, Cecilie Okholm, Michael Patrick Achiam, Lars Bo Svendsen, Frank Viborg Mortensen, High Age Increases the Risk of Complications and Reduces Survival Following Esophagectomy for Adenocarcinoma, Journal of Surgery. Vol. 6, No. 1, 2018, pp. 1-7. doi: 10.11648/j.js.20180601.11
Copyright
Copyright © 2017 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Pennathur A, Gibson MK, Jobe BA, Luketich JD: Oesophageal carcinoma. Lancet 2013, 381 (9864): 400-412.
[2]
Samalin E, Ychou M: Neoadjuvant therapy for gastroesophageal adenocarcinoma. World journal of clinical oncology 2016, 7 (3): 284-292.
[3]
Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of surgery 2004, 240 (2): 205-213.
[4]
Low DE, Alderson D, Cecconello I, Chang AC, Darling GE, D'Journo XB, Griffin SM, Holscher AH, Hofstetter WL, Jobe BA, Kitagawa Y, Kucharczuk JC, Law SY, Lerut TE, Maynard N, Pera M, Peters JH, Pramesh CS, Reynolds JV, Smithers BM, van Lanschot JJ: International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Annals of surgery 2015, 262 (2): 286-294.
[5]
Lewis I: The surgical treatment of carcinoma of the oesophagus; with special reference to a new operation for growths of the middle third. The British journal of surgery 1946, 34: 18-31.
[6]
Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of chronic diseases 1987, 40 (5): 373-383.
[7]
Backemar L, Lagergren P, Johar A, Lagergren J: Impact of co-morbidity on mortality after oesophageal cancer surgery. The British journal of surgery 2015, 102 (9): 1097-1105.
[8]
Donders AR, van der Heijden GJ, Stijnen T, Moons KG: Review: a gentle introduction to imputation of missing values. Journal of clinical epidemiology 2006, 59 (10): 1087-1091.
[9]
Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR: Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. Bmj 2009, 338: b2393.
[10]
DECV annual report. http://decvgicancerdk/Defaultaspx?pID=17 2014.
[11]
Turrentine FE, Wang H, Simpson VB, Jones RS: Surgical risk factors, morbidity, and mortality in elderly patients. Journal of the American College of Surgeons 2006, 203 (6): 865-877.
[12]
Byrne BE, Mamidanna R, Vincent CA, Faiz O: Population-based cohort study comparing 30- and 90-day institutional mortality rates after colorectal surgery. The British journal of surgery 2013, 100 (13): 1810-1817.
[13]
Oakley B, Lamb C, Vohra R, Catton J: Achieving long term survival in oesophagectomy patients aged over 75. Annals of medicine and surgery (2012) 2016, 9: 15-21.
[14]
Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, Participants MT: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. The New England journal of medicine 2006, 355 (1) 11-20.
[15]
Allum WH, Stenning SP, Bancewicz J, Clark PI, Langley RE: Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2009, 27 (30): 5062-5067.
[16]
Backemar L, Lagergren P, Djarv T, Johar A, Wikman A, Lagergren J: Comorbidities and Risk of Complications After Surgery for Esophageal Cancer: A Nationwide Cohort Study in Sweden. World journal of surgery 2015, 39 (9): 2282-2288.
[17]
[17] Gorissen KJ, Benning D, Berghmans T, Snoeijs MG, Sosef MN, Hulsewe KW, Luyer MD: Risk of anastomotic leakage with non-steroidal anti-inflammatory drugs in colorectal surgery. The British journal of surgery 2012, 99 (5): 721-727.
[18]
Klein M, Gogenur I, Rosenberg J: Postoperative use of non-steroidal anti-inflammatory drugs in patients with anastomotic leakage requiring reoperation after colorectal resection: cohort study based on prospective data. Bmj 2012, 345: e6166.
[19]
Escofet X, Manjunath A, Twine C, Havard TJ, Clark GW, Lewis WG: Prevalence and outcome of esophagogastric anastomotic leak after esophagectomy in a UK regional cancer network. Diseases of the esophagus: official journal of the International Society for Diseases of the Esophagus / ISDE 2010, 23 (2): 112-116.
[20]
Patil PK, Patel SG, Mistry RC, Deshpande RK, Desai PB: Cancer of the esophagus: esophagogastric anastomotic leak--a retrospective study of predisposing factors. Journal of surgical oncology 1992, 49 (3): 163-167.
[21]
Petersen TI, Pahle E, Sommer T, Zilling T: Laparoscopic minimally invasive total gastrectomy with linear stapled oesophagojejunostomy--experience from the first thirty procedures. Anticancer research 2013, 33 (8): 3269-3273.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186